Numerai GP LLC Purchases New Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Numerai GP LLC acquired a new position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 16,061 shares of the company's stock, valued at approximately $372,000. Numerai GP LLC owned 0.07% of OrthoPediatrics at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in KIDS. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of OrthoPediatrics by 25.5% during the 4th quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 65,292 shares of the company's stock valued at $1,513,000 after buying an additional 13,270 shares in the last quarter. Millennium Management LLC purchased a new stake in OrthoPediatrics in the 4th quarter valued at about $9,798,000. Deutsche Bank AG grew its position in OrthoPediatrics by 57.1% in the 4th quarter. Deutsche Bank AG now owns 14,393 shares of the company's stock valued at $334,000 after acquiring an additional 5,233 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in shares of OrthoPediatrics during the fourth quarter worth about $461,000. Finally, Northern Trust Corp boosted its holdings in OrthoPediatrics by 0.3% in the fourth quarter. Northern Trust Corp now owns 193,798 shares of the company's stock valued at $4,492,000 after purchasing an additional 644 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company's stock.

Analyst Ratings Changes

KIDS has been the subject of several analyst reports. Lake Street Capital initiated coverage on OrthoPediatrics in a research note on Monday, April 7th. They set a "buy" rating and a $37.00 price target for the company. Stifel Nicolaus lowered their target price on OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a report on Wednesday, March 5th. Piper Sandler decreased their price objective on OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating on the stock in a research note on Thursday, May 8th. Truist Financial reduced their target price on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Thursday, May 8th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, OrthoPediatrics presently has an average rating of "Moderate Buy" and an average target price of $35.83.

Insider Transactions at OrthoPediatrics

In other news, insider Gregory A. Odle sold 5,359 shares of OrthoPediatrics stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the transaction, the insider now owns 148,788 shares in the company, valued at approximately $3,698,869.68. The trade was a 3.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, General Counsel Daniel J. Gerritzen sold 5,310 shares of the company's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $132,006.60. Following the completion of the transaction, the general counsel now directly owns 110,767 shares in the company, valued at approximately $2,753,667.62. The trade was a 4.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 23,732 shares of company stock valued at $589,978 over the last three months. Company insiders own 32.70% of the company's stock.

OrthoPediatrics Price Performance

Shares of KIDS traded down $0.12 during midday trading on Monday, reaching $22.95. The stock had a trading volume of 63,845 shares, compared to its average volume of 196,666. OrthoPediatrics Corp. has a 52 week low of $20.25 and a 52 week high of $35.99. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The firm's 50 day moving average price is $22.86 and its 200-day moving average price is $23.95. The company has a market capitalization of $557.39 million, a P/E ratio of -18.66 and a beta of 1.09.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). The firm had revenue of $52.41 million during the quarter, compared to the consensus estimate of $51.68 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. On average, analysts forecast that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.